New Antidepressant Pharmaceutical Analysis Reported in the New York Times

Posted on January 6, 2010 by Breanna Wilson

This article regarding a new analysis on antidepressant pharmaceuticals such as GlaxoSmithKline's Paxil, appeared in yesterday's New York Times.  According to the analysis, antidepressants effectiveness is directly correlated with the severity of the depression being treated.  Will findings like this slow down doctors from prescribing antidepressants to patients whose "depression" could only be due to something as simple as PMS or one bad day?

We want to hear what you think!  In your opinion, are doctors writing unnecessary prescriptions? 

Tags: , , , ,
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.consumeradvocatelegalupdate.com/admin/trackback/175692
Comments (1) Read through and enter the discussion with the form at the end
Robin Farquharson - January 9, 2010 8:10 AM


I take 20mg Paxil everyday. As a result I'm no longer on an emotional fairground ride. Life is much better, calmer, more confident. I take the daily average good & the bad as it comes, and deal with it all step by step. "No Worries, Mate!"

Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.